Abstract:Objective: The immune-privileged microenvironment plays a critical role in immune escape of acute myeloid leukemia (AML), however the characteristics of the immune micro-environment in pre-leukemia states have not yet been clarified. In this study, the Aml1Eto/+; Mx1-Cre mouse model was employed to explore the remodeling of the immune microenvironment by leukemic precursor cells, and to elucidate the characteristics of the immune microenvironment in the pre-leukemic state. Methods: Four weeks after PIPC induction (5mg/kg), bone marrow-derived immune cells such as T cells, B cells and macrophages(Mφ) that do not express the AML1-ETO (AE) fusion gene were sorted from Aml1Eto/+; Mx1-Cre mice (experimental group) and Aml1Eto/+;w/o Mx1-Cre mice (control group), respectively. The immune cell subsets were analyzed using CIBERSORT after bulk RNA-sequence, and TCR and BCR information was reconstructed by TRUST4. Results: After PIPC induction, the proportion of the AE fusion gene expressed hematopoietic precursors cells expanded significantly in the experiment group. The absolute counts of T cells and dendritic cells that did not express the fusion gene showed a considerable increment (p<0.0001; p=0.0067), and the monocyte-macrophage cells decreased (p<0.0001; p=0.0009). In addition, the expressions of Gzma and other cytotoxicity-related genes were significantly up-regulated in the T cells of experiment group. As for reconstructed TCR, the clonal diversity of TCR expanded. Although the proportion and absolute count of T cell increased when AE fusion protein induced, there didn't appear some hyperexpanded clones. The clonotype relative abundance and gene usage preference of TCR & BCR are similar between experiment and control group. There were 11 pre-leukemia-specific TCR amino acid sequences appeared, though no dominant clone was formed, suggesting that T cells produced relevant but not strong enough immune responses to pre-leukemia precursor cells. Further analysis found that the T cells in experiment group were composed of more Treg cells and expressed higher exhaustion-related genes such as PD-1, indicated that T cells began to accumulate negative immune regulation pathways in the bone marrow microenvironment of pre-leukemic state. For the antigen presentation, the expression of MHC-I molecules on AE fusion gene expressed LT-HSC and GMP in the experimental group was up-regulated, while the expressions of MHC-I and MHC-II molecules in dendritic cells were not significantly different from those in the control group. Meanwhile, CIBERSORT and flow cytometry analysis showed more classically activated M1-Mφ in the experiment group, in which the expressions of INF-γ, IL-1, and other genes were up-regulated. In terms of B cells, the production of immunoglobulins related genes and antigen processing and presenting genes were up-regulated. The BCR clonal diversity expanded, and 73 pre-leukemia-specific BCR amino acid sequences appeared, but no dominant clones were formed. Among the heavy chain sequences, the clonal diversity of IgD and IgM in the experimental group increased, the relative abundance of IgM increased, and the relative abundance of IgA decreased. Conclusion: We performed a comprehensive cell-type based dissection of the AML1-ETO fusion gene induced pre-leukemia immune microenvironment. The results demonstrates that in pre-leukemia stage, activated immune microenvironment is involved in the fight with AML1-ETO expressed cells. And there is also an accumulation of negative immune regulation mechanisms which may potentially contribute to weaken "the power" of immune surveillance. Although further validation is required, restoring dysfunctional immune cells or enhance the AML1-ETO specific immune response might be a potential early therapeutic approach for patients.

Heme oxygenase-1 inhibits the cytotoxicity of natural killer cells to acute myeloid leukemia by downregulating human leukocyte antigen-C

Homoharringtonine Exhibits Potent Anti-Tumor Effect and Modulates DNA Epigenome in Acute Myeloid Leukemia by Targeting SP1/TET1/5hmC.

A Novel Role for Malate Dehydrogenase 1 in Acute Myeloid Leukemia Progression

Homoharringtonine Affects the Jak2-Stat5 Signal Pathway Through Alteration of Protein Tyrosine Kinase Phosphorylation in Acute Myeloid Leukemia Cells

Targeting CaMKII-δ/DHCR24 Axis is a Novel Strategy Against Acute Myeloid Leukemia

In vivo and in vitro effects of heme oxygenase-1 silencing on the survival of acute myelocytic leukemia-M2 cells

AML cell‐derived exosomes suppress the activation and cytotoxicity of NK cells in AML via PD‐1/PD‐L1 pathway

PD-1H/VISTA mediates immune evasion in acute myeloid leukemia

Activation of non-classical Wnt signaling pathway effectively enhances HLA-A presentation in acute myeloid leukemia

Acute myeloid leukaemia cells secrete a soluble factor that inhibits T and NK cell proliferation but not cytolytic function – implications for the adoptive immunotherapy of leukaemia

Homoharringtonine deregulates MYC transcriptional expression by directly binding NF-κB repressing factor

Acute Myeloid Leukemia Epigenetic Immune Escape From Nature Killer Cells by ICAM-1

FLIP regulation of HO-1 and TNF signalling in human acute myeloid leukemia provides a unique secondary anti-apoptotic mechanism

Acute Myeloid Leukaemia Induces Natural Killer Cell Exhaustion Through Inhibition of the PI3K-AKT Pathway

Suppressing Hedgehog signaling reverses drug resistance of refractory acute myeloid leukemia

HIF1α drives chemokine factor pro-tumoral signaling pathways in acute myeloid leukemia

Chronic Inflammation Deters Natural Killer Cell Fitness and Cytotoxicity in Myeloid Leukemia

Hyperfunction of CD4 CD25 Regulatory T Cells in De Novo Acute Myeloid Leukemia.

HVEM in acute lymphocytic leukemia facilitates tumour immune escape by inhibiting CD8+ T cell function

Silencing HO-1 sensitizes SKM-1 cells to apoptosis induced by low concentration 5-azacytidine through enhancing p16 demethylation

The Characteristics of AML1-ETO Fusion Gene Induced Pre-Leukemia Immune Microenvironment